Image_2_Skin Mast Cells Contribute to Sporothrix schenckii Infection.TIF
Background:Sporothrix schenckii (S. schenckii), a dimorphic fungus, causes sporotrichosis. Mast cells (MCs) have been described to be involved in skin fungal infections. The role of MCs in cutaneous sporotrichosis remains largely unknown.
Objectives: To characterize the role and relevance of MCs in cutaneous sporotrichosis.
Methods: We analyzed cutaneous sporotrichosis in wild-type (WT) mice and two different MC-deficient strains. In vitro, MCs were assessed for S. schenckii-induced cytokine production and degranulation after incubation with S. schenckii. We also explored the role of MCs in human cutaneous sporotrichosis.
Results: WT mice developed markedly larger skin lesions than MC-deficient mice (> 1.5 fold) after infection with S. schenckii, with significantly increased fungal burden. S. schenckii induced the release of tumor necrosis factor alpha (TNF), interleukin (IL)-6, IL-10, and IL-1β by MCs, but not degranulation. S. schenckii induced larger skin lesions and higher release of IL-6 and TNF by MCs as compared to the less virulent S. albicans. In patients with sporotrichosis, TNF and IL-6 were increased in skin lesions, and markedly elevated levels in the serum were linked to disease activity.
Conclusions: These findings suggest that cutaneous MCs contribute to skin sporotrichosis by releasing cytokines such as TNF and IL-6.
History
References
- https://doi.org//10.2165/00128071-200304080-00003
- https://doi.org//10.1038/nri2782
- https://doi.org//10.4049/jimmunol.1203420
- https://doi.org//10.1111/exd.13907
- https://doi.org//10.1016/0041-0101(74)90233-5
- https://doi.org//10.1007/s10753-014-9951-9
- https://doi.org//10.1186/s12879-014-0713-y
- https://doi.org//10.1038/srep12287
- https://doi.org//10.1016/j.imbio.2015.09.004
- https://doi.org//10.2741/990
- https://doi.org//10.1128/IAI.72.9.4996-5003.2004
- https://doi.org//10.1590/S0036-46652005000500006
- https://doi.org//10.1007/s11046-006-0069-y
- https://doi.org//10.4049/jimmunol.0800885
- https://doi.org//10.1111/j.1398-9995.2010.02437.x
- https://doi.org//10.1111/j.1365-3083.2012.02706.x
- https://doi.org//10.1016/j.jaci.2013.03.047
- https://doi.org//10.1152/ajpgi.00070.2013
- https://doi.org//10.1093/mmy/myu055
- https://doi.org//10.1016/j.bbrc.2015.10.154
- https://doi.org//10.1016/j.imbio.2016.12.001
- https://doi.org//10.1016/j.jdermsci.2017.03.002
- https://doi.org//10.3389/fimmu.2012.00146
- https://doi.org//10.1086/522765
- https://doi.org//10.1111/j.1365-2567.2009.03118.x
- https://doi.org//10.4161/viru.23112
- https://doi.org//10.1007/s00284-016-1045-5
- https://doi.org//10.1038/s41598-018-22709-8
- https://doi.org//10.1155/2016/6525831
- https://doi.org//10.1155/2014/272376
- https://doi.org//10.1016/j.tins.2013.06.001
- https://doi.org//10.3389/fimmu.2012.00185
- https://doi.org//10.1007/s11046-012-9523-1
- https://doi.org//10.3109/08820139.2013.879174
- https://doi.org//10.5114/ceji.2016.65131
- https://doi.org//10.1007/s11046-009-9190-z
- https://doi.org//10.1016/j.it.2012.09.008
- https://doi.org//10.1128/IAI.00053-17
- https://doi.org//10.1186/s40249-019-0560-6
- https://doi.org//10.1007/BF01102920
- https://doi.org//10.1016/S1286-4579(01)01373-9
- https://doi.org//10.1111/j.1365-2567.2007.02712.x
- https://doi.org//10.1086/377235
- https://doi.org//10.1155/2015/614504
- https://doi.org//10.1046/j.1365-280X.1999.00239.x
- https://doi.org//10.1046/j.1365-3083.2003.01175.x
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity
CC BY 4.0